Navigating the Intersection of COVID-19 and Avascular Necrosis: Challenges and Opportunities for Patient Management

Pharamaceutical education

Avascular necrosis (AVN) is a debilitating condition characterized by the death of bone tissue due to inadequate blood supply, often leading to severe pain and disability. The COVID-19 pandemic has significantly disrupted healthcare systems worldwide, raising critical concerns regarding its implications for patients with AVN. This review aims to synthesize current knowledge on the effects of COVID-19 on AVN patients, including exacerbation of symptoms, treatment challenges, and recommendations for management. Notably, the intersection of COVID-19 with AVN presents unique challenges, such as increased thromboembolic risks and complications from corticosteroid use, which are commonly prescribed during severe COVID-19 cases. Furthermore, the psychological impact of the pandemic on patients, including anxiety and depression related to both their condition and fear of COVID-19, warrants attention. This review highlights the need for a multidisciplinary approach to manage AVN in the context of COVID-19 effectively.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.